Related Experiment Video
Updated: Oct 19, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
COVID-19 Pediatric Dermatology
Holly Neale1, Elena B Hawryluk2
1Department of Dermatology, Massachusetts General Hospital, Boston, MA, USA; University of Massachusetts Medical School, Worcester, MA, USA.
Insights
Pediatric COVID-19 skin manifestations can be the sole indicator of infection. Recognizing these unique dermatologic signs is crucial for timely diagnosis and management in children.
Area of Science:
- Pediatric Infectious Diseases
- Dermatology
- Public Health
Background:
- Children exhibit distinct COVID-19 presentations, often asymptomatic or mild.
- Cutaneous manifestations can be the primary or sole sign of infection in pediatric cases.
- Understanding these skin signs is vital for infection control and patient management.
Purpose of the Study:
- To describe the presentation of skin manifestations in children with COVID-19.
- To review pathophysiologic theories behind pediatric COVID-19 dermatologic findings.
- To outline management strategies for cutaneous manifestations of COVID-19 in children.
Main Methods:
- Literature review of pediatric COVID-19 cases with dermatologic involvement.
- Analysis of reported skin lesion types and frequencies in children.
- Synthesis of current understanding of viral-skin interactions in pediatric SARS-CoV-2 infection.
Main Results:
- Pediatric COVID-19 skin findings range from common viral exanthems to specific patterns like chilblains.
- Some dermatologic signs in children differ in frequency or presentation compared to adults.
- Cutaneous signs may indicate broader systemic involvement or sequelae.
Conclusions:
- Cutaneous manifestations are significant indicators of COVID-19 in children.
- Early recognition of pediatric skin signs aids in prompt diagnosis and public health measures.
- Further research into the pathophysiology and long-term implications of these findings is warranted.
Abstract:
Children are a unique subset of patients in relation to the COVID-19 pandemic, often presenting asymptomatically, mildly, or atypically. Manifestations of the skin may be a primary (or the only) presenting sign. Recognizing cutaneous manifestations of COVID-19 in the pediatric population is important to guiding precautions, testing, and management for patients and close contacts. Whereas some dermatologic signs in children overlap with those in adults, other skin findings are reported with higher frequency in children and may be clues to multisystemic sequelae. This article describes presentation, pathophysiologic theories, and management strategies for cutaneous manifestations of COVID-19 in children.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

